DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 46 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,991,662 | +5.0% | 488,318 | +2.1% | 0.08% | +8.3% |
| Q2 2023 | $5,708,586 | -9.5% | 478,106 | +1.3% | 0.07% | -19.1% |
| Q1 2023 | $6,309,089 | -39.4% | 471,884 | -2.4% | 0.09% | -42.6% |
| Q4 2022 | $10,404,576 | +6.0% | 483,484 | -1.3% | 0.16% | +4.0% |
| Q3 2022 | $9,814,000 | +9.3% | 489,972 | -2.3% | 0.15% | +2.8% |
| Q2 2022 | $8,980,000 | +124.4% | 501,689 | +24.3% | 0.14% | +195.9% |
| Q1 2022 | $4,002,000 | -42.2% | 403,458 | -1.9% | 0.05% | -31.0% |
| Q4 2021 | $6,929,000 | -32.3% | 411,207 | -4.7% | 0.07% | -41.3% |
| Q3 2021 | $10,238,000 | +3.5% | 431,446 | -0.7% | 0.12% | -7.6% |
| Q2 2021 | $9,892,000 | – | 434,423 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,548,403 | $54,841,633 | 43.06% |
| PATHWAY CAPITAL MANAGEMENT, LP | 995,686 | $21,427,163 | 38.24% |
| Atlas Venture Life Science Advisors, LLC | 7,568,317 | $162,870,182 | 19.62% |
| RA Capital Management | 7,040,622 | $151,514,185 | 3.07% |
| COMMODORE CAPITAL LP | 739,661 | $15,918 | 2.40% |
| GREAT POINT PARTNERS LLC | 544,451 | $11,716,586 | 2.30% |
| Nicholas Investment Partners, LP | 786,554 | $16,926,642 | 1.48% |
| Boxer Capital, LLC | 1,189,943 | $25,607,573 | 1.35% |
| Parkman Healthcare Partners LLC | 224,483 | $4,830,874 | 1.29% |
| Cheyne Capital Management (UK) LLP | 27,223 | $585,839 | 1.02% |